Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Fabien, Chaillot"'
Autor:
Mathieu Bellal, Julien Lelandais, Thomas Chabin, Aurélie Heudron, Thomas Gourmelon, Pierrick Bauduin, Pierre Cuchet, Cédric Daubin, Célia De Carvalho Ribeiro, Augustin Delcampe, Suzanne Goursaud, Aurélie Joret, Martin Mombrun, Xavier Valette, Damiano Cerasuolo, Rémy Morello, Patrick Mordel, Fabien Chaillot, Jean Jacques Dutheil, Denis Vivien, Damien Du Cheyron
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
BackgroundPain management is an essential and complex issue for non-communicative patients undergoing sedation in the intensive care unit (ICU). The Behavioral Pain Scale (BPS), although not perfect for assessing behavioral pain, is the gold standard
Externí odkaz:
https://doaj.org/article/3b388c35d06f4c3d9e1e64dbe00b3511
Autor:
Rémy Morello, Yassine Eid, Véronique Bouvier, Olivier Dejardin, Benjamin Menahem, Fabien Chaillot, Yannick Chene, Jean Jacques Dutheil, Therese Juul, Arnaud Alves
Publikováno v:
BMJ Open, Vol 10, Iss 3 (2020)
Introduction Many bowel problems following low anterior resection (LAR) for rectal cancer considerably impair the quality of life (QoL) of patients. The LAR syndrome (LARS) scale is a self-report questionnaire to identify and assess bowel dysfunction
Externí odkaz:
https://doaj.org/article/2c170b80d5ed4c30b03e747f22f92741
Autor:
David R. Bangsberg, Jean Jacques Dutheil, Elodie Morilland-Lecoq, Laurent Cotte, P. Perré, A. Fournier, Matthias Cavassini, Fabien Chaillot, Manuel Etienne, Thierry Prazuck, Amandine Gagneux-Brunon, Guillemette Unal, Marie Paule Schneider, Jean-Jacques Parienti, Laurent Hocqueloux, Renaud Verdon
Publikováno v:
Open Forum Infectious Diseases
Open forum infectious diseases, vol. 8, no. 7, pp. ofab316
Open forum infectious diseases, vol. 8, no. 7, pp. ofab316
Background For many people with HIV (PWH), taking antiretroviral therapy (ARV) every day is difficult. Methods Average adherence (Av-Adh) and log-transformed treatment interruption (TI) to ARV were prospectively measured over 6 months using electroni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2084b639eb52e161c7a63cb7282ee19
http://europepmc.org/articles/PMC8297697
http://europepmc.org/articles/PMC8297697
Autor:
Elodie, Delavoipière, Chloé, Fourage, Margaret, Macro, Pascale, Olivier-Abbal, Camille, Fleck, Catherine, Mouchel, Marylaure, Gavard, Nadine, Petitpain, Charlotte, Muller, Marie-Paule, Franceschi, Christine, Savary, François, Fournel, Fabien, Chaillot, Antoine, Alix, Laure, Peyro-Saint-Paul
Publikováno v:
Thérapie
Thérapie, EDP Sciences, 2021, ⟨10.1016/j.therap.2021.02.002⟩
Thérapie, EDP Sciences, 2021, 76 (6), pp.735-742. ⟨10.1016/j.therap.2021.02.002⟩
Therapies
Therapies, 2021, 76 (6), pp.735-742. ⟨10.1016/j.therap.2021.02.002⟩
Thérapie, EDP Sciences, 2021, ⟨10.1016/j.therap.2021.02.002⟩
Thérapie, EDP Sciences, 2021, 76 (6), pp.735-742. ⟨10.1016/j.therap.2021.02.002⟩
Therapies
Therapies, 2021, 76 (6), pp.735-742. ⟨10.1016/j.therap.2021.02.002⟩
National audience; The investigational drugs circuit has specific risks, and medication errors may occur in clinical trials, possibly associated with adverse reactions. These risks must therefore be managed. In fact, there are few reports of medicati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::f7788dfe34f25129a06669c393396e14
https://hal.archives-ouvertes.fr/hal-03190729/document
https://hal.archives-ouvertes.fr/hal-03190729/document
Autor:
Marylaure Gavard, Pascale Olivier-Abbal, Christine Savary, Nadine Petitpain, Antoine Alix, Fabien Chaillot, Laure Peyro-Saint-Paul, Margaret Macro, Charlotte Muller, Chloé Fourage, Marie-Paule Franceschi, François Fournel, Revise, Catherine Mouchel, Elodie Delavoipière, Camille Fleck
Publikováno v:
Therapies
Therapies, 2021, 76 (6), pp.735-742. ⟨10.1016/j.therap.2021.02.002⟩
Therapies, 2021, 76 (6), pp.735-742. ⟨10.1016/j.therap.2021.02.002⟩
National audience; The investigational drugs circuit has specific risks, and medication errors may occur in clinical trials, possibly associated with adverse reactions. These risks must therefore be managed. In fact, there are few reports of medicati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e57be8b3b0b35042f27fcb3ee0f88f6
https://doi.org/10.1016/j.therap.2021.02.002
https://doi.org/10.1016/j.therap.2021.02.002
Autor:
Yannick Chene, Therese Juul, Olivier Dejardin, Fabien Chaillot, Arnaud Alves, Y. Eid, Jean Jacques Dutheil, Benjamin Menahem, Rémy Morello, Véronique Bouvier
Publikováno v:
BMJ Open
Eid, Y, Bouvier, V, Dejardin, O, Menahem, B, Chaillot, F, Chene, Y, Dutheil, J J, Juul, T, Morello, R & Alves, A 2020, ' 'French LARS score' : validation of the French version of the low anterior resection syndrome (LARS) score for measuring bowel dysfunction after sphincter-preserving surgery among rectal cancer patients: a study protocol ', BMJ Open, vol. 10, no. 3, e034251 . https://doi.org/10.1136/bmjopen-2019-034251
Eid, Y, Bouvier, V, Dejardin, O, Menahem, B, Chaillot, F, Chene, Y, Dutheil, J J, Juul, T, Morello, R & Alves, A 2020, ' 'French LARS score' : validation of the French version of the low anterior resection syndrome (LARS) score for measuring bowel dysfunction after sphincter-preserving surgery among rectal cancer patients: a study protocol ', BMJ Open, vol. 10, no. 3, e034251 . https://doi.org/10.1136/bmjopen-2019-034251
IntroductionMany bowel problems following low anterior resection (LAR) for rectal cancer considerably impair the quality of life (QoL) of patients. The LAR syndrome (LARS) scale is a self-report questionnaire to identify and assess bowel dysfunction
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e13dab69ac925ffb00fd53ba869aa607
http://europepmc.org/articles/PMC7064062
http://europepmc.org/articles/PMC7064062
Autor:
Renaud Verdon, Jean-Jacques Parienti, Gwenaël Le Moal, Véronique Massari, Fabien Chaillot, Astrid Vabret, Cédric Arvieux, Véronique Reliquet
Publikováno v:
AIDS. 21:2217-2222
OBJECTIVE: For optimal adherence, once-daily dosing is best. Whether this applies to antiretroviral therapy is unknown. We thus aimed to determine the effect of once-daily dosing on adherence to nevirapine. DESIGN: A three-phase (3-month observationa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4eb9c0de03cefc22744e820c22b54e8
https://doi.org/10.1097/qad.0b013e3282eff388
https://doi.org/10.1097/qad.0b013e3282eff388